Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MIMEDX GROUP, INC. Director's Dealing 2025

Feb 18, 2025

32206_dirs_2025-02-18_2f0d3434-f4e6-429f-9e54-cdb54db886ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MIMEDX GROUP, INC. (MDXG)
CIK: 0001376339
Period of Report: 2025-02-13

Reporting Person: Whitlow Ricci S (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-02-13 Common Stock S 61420 $8.28 Disposed 403019 Direct

Footnotes

F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2: Includes an aggregate of 4,911 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan